Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10675482
Device and method for use of photodynamic therapy
granted -
US 10661095
Photodynamic therapy for use in treating cancer
granted -
US 10653789
Polymer-drug conjugates for combination anticancer therapy
granted -
US 10653723
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 10653710
Combination therapy for treating malignancies
granted -
US 10646517
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10639330
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10632114
Pyruvate kinase activators for use in therapy
granted -
US 10618967
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
granted -
US 10610535
Diarylpropionitrile therapy for treatment of multiple sclerosis
granted -
US 10576096
Tumor-selective combination therapy
granted -
US 10568873
Safranal-sorafenib combination therapy for liver cancer
granted -
US 10568963
Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles
granted -
US 10544223
Combination therapy with an anti-axl antibody-drug conjugate
granted -
US 10543222
Therapy for inhibition of single-stranded RNA virus replication
granted -
US 10537595
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10537635
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted -
US 10533227
Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
granted -
US 10525104
Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer
granted -
US 10526414
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10517948
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 10493162
Somatostatin receptor-based cancer therapy
granted -
US 10485886
Core-satellite nanocomposites for MRI and photothermal therapy
granted -
US 10488416
Targeting breast cancer therapy based on stromal subtypes and CD146 composition
granted